The Future of Population Health Management: Artificial Intelligence as a Cost-Effective Behavior Change and Chronic Disease Prevention and Management Solution

Stein, Natalie

doi:10.15406/mojph.2017.06.00188

Cited by 3 publications

(1 citation statement)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…They are particularly innovative in the healthcare and mental health space, and initial research shows that they have potential to positively impact care (McGreevey, William Hanson, & Koppel, 2020). Especially in population health management, chatbots and artificial intelligence can complement providers to scale patient reach and promote population‐based recommendations, while simultaneously tailoring care to individual patients (Stein, 2017).…”

Section: Scaling Genetics In Healthcare: the Futurementioning

confidence: 99%

Democratizing genomics: Leveraging software to make genetics an integral part of routine care

Snir

Nazareth

Simmons

et al. 2020

American J of Med Genetics Pt C

View full text Add to dashboard Cite

Genetic testing can provide definitive molecular diagnoses and guide clinical management decisions from preconception through adulthood. Innovative solutions for scaling clinical genomics services are necessary if they are to transition from a niche specialty to a routine part of patient care. The expertise of specialists, like genetic counselors and medical geneticists, has traditionally been relied upon to facilitate testing and follow‐up, and while ideal, this approach is limited in its ability to integrate genetics into primary care. As individuals, payors, and providers increasingly realize the value of genetics in mainstream medicine, several implementation challenges need to be overcome. These include electronic health record integration, patient and provider education, tools to stay abreast of guidelines, and simplification of the test ordering process. Currently, no single platform offers a holistic view of genetic testing that streamlines the entire process across specialties that begins with identifying at‐risk patients in mainstream care settings, providing pretest education, facilitating consent and test ordering, and following up as a “genetic companion” for ongoing management. We describe our vision for using software that includes clinical‐grade chatbots and decision support tools, with direct access to genetic counselors and pharmacists within a modular, integrated, end‐to‐end testing journey.

show abstract

Section: Scaling Genetics In Healthcare: the Futurementioning

confidence: 99%